A study of the impact of a written action plan and multi-disciplinary (respiratory specialist nurse led) intervention in preventing re-admission and improving quality of life through better disease management in patients admitted with an exacerbation
| ISRCTN | ISRCTN70191324 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN70191324 |
| Protocol serial number | N0107162719 |
| Sponsor | Record Provided by the NHSTCT Register - 2006 Update - Department of Health |
| Funders | Hertfordshire Hospitals Research and Development Consortium (UK), NHS R&D Support Funding |
- Submission date
- 29/09/2006
- Registration date
- 29/09/2006
- Last edited
- 21/09/2012
- Recruitment status
- Stopped
- Overall study status
- Stopped
- Condition category
- Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Indranil Chakravorty
Scientific
Scientific
Department of Respiratory Medicine
Lister Hospital
Coreys Mill Lane
Stevenage
SG1 4AB
United Kingdom
| Phone | +44 01438 314333 ext. 5869 |
|---|---|
| indranil.chakravorty@nhs.net |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | |
| Study objectives | Not provided at time of registration |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Respiratory: Asthma |
| Intervention | A randomised, controlled trial of a self-management protocol 'Action Plan' against conventional treatment, I patients who are admitted with an acute exacerbation of a COPD or a fter a visit to the OP clinic (with a history of admission within the last 6 months). All patients would undergo baseline spirometry with assessment of reversibility to salbutamol in order to diagnose COPD and exclude asthma. Patients randomised to the intervention group would receive: 1. Education about the nature of disease, risk factors, progression, pathophysiology of exacerbations and basic principles of management 2. Smoking cession 3. Nutritional assessment 4. Physiotherapy advice on the potential for exercise and pulmonary rehabilitating 5. Respiratory assessment 21/09/2012: Please note that this trial was stopped due to a lack of funding. |
| Intervention type | Drug |
| Phase | Not Specified |
| Drug / device / biological / vaccine name(s) | Salbutamol |
| Primary outcome measure(s) |
Not provided at time of registration |
| Key secondary outcome measure(s) |
Not provided at time of registration |
| Completion date | 01/03/2009 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Key inclusion criteria | Not provided at time of registration |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/04/2005 |
| Date of final enrolment | 01/03/2009 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
Department of Respiratory Medicine
Stevenage
SG1 4AB
United Kingdom
SG1 4AB
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
